Our objectives in reporting this case series are to familiarize readers with the rare occurrence of paragangliomas originating along the facial nerve and to provide a literature review.
Introduction
Paragangliomas are rare tumors derived from nonchromaffin paraganglion cells distributed throughout the head and neck. 1 They may occur sporadically or as part of a hereditary syndrome such as multiple endocrine neoplasia type 2 , von Hippel-Lindau syndrome, or neurofibromatosis type 1. 2 Paragangliomas represent 0.6% of all head and neck tumors, with most being benign. Approximately 10% of cases feature histopathologic criteria for malignancy. 2 These tumors most commonly originate in paraganglionic tissue in the area of the carotid bifurcation (carotid body tumors). Head and neck sites include the jugular foramen (glomus jugulare), vagus nerve (glomus vagale), and the tympanic plexus (glomus tympanicum). 2, 3 Paragangliomas originating in the facial nerve (glomus faciale) are extraordinarily rare, as only 12 such cases have been previously reported in the literature (table) . 2, [4] [5] [6] [7] [8] [9] [10] [11] [12] Given their rarity, the optimal management is unclear.
In this article, we present 3 new cases of facial nerve paraganglioma, and we review the literature.
Case reports Patient 1.
A 48-year-old woman presented to our medical center with a progressively enlarging left parotid mass and left pulsatile tinnitus of 3 months' duration. Her medical history was significant for hypertension.
Physical examination revealed normal facial nerve function (House-Brackmann grade I). Findings on the remainder of the head and neck examination, which included microscopic otoscopy, were unremarkable. Puretone audiometry revealed normal hearing bilaterally.
The patient underwent two fine-needle aspiration biopsies, the results of which were both inconclusive. Magnetic resonance imaging (MRI) of the skull base revealed a 1.9 × 1.4 × 1.7-cm mass in the left parotid gland with extension toward the stylomastoid foramen. The tumor enhanced on T1-weighted MRI, which showed The patient underwent a left superficial parotidectomy. Dissection of the facial nerve was performed from proximal to distal, and the tumor appeared to have either originated in the facial nerve or invaded the nerve. The vertical segment of the facial nerve was abnormally thickened. Stimulation of the facial nerve elicited a normal response. A segment of the tumor was biopsied and sent for pathologic evaluation.
Because the patient's preoperative facial nerve function was normal, the tumor was not resected. Instead, a transmastoid facial nerve decompression was performed to allow the tumor to grow without compromising facial nerve function. At the completion of the procedure, the facial nerve was again stimulated, and the response was normal.
Histopathologic evaluation of the specimen identified small epithelial cells arranged in an organoid-nesting (Zellballen) pattern ( figure 1, B ). Immunohistochemistry was positive for synaptophysin and S-100 protein and negative for LCA and pankeratin. All these findings supported the diagnosis of paraganglioma.
At a follow-up visit 8 years later, the patient continued to exhibit normal facial nerve function and a well-healed incision. She reported occasional left-sided pulsatile tinnitus but was otherwise asymptomatic. Pure-tone audiometry revealed normal hearing bilaterally. An MRI obtained at this follow-up revealed 4 mm of tumor growth over 8 years.
Patient 2.
A 66-year-old man presented to our institution with a 1-year history of right-sided hearing loss, aural fullness, and pulsatile tinnitus. His medical history was significant for hypertension.
Microscopic otoscopy detected a reddish, pulsatile soft-tissue mass in the right ear canal. The middle ear did not appear to be involved, and the tympanic membrane was intact with normal landmarks. Findings on the remainder of the head and neck examination, which included an assessment of facial nerve function, were normal. Audiometry revealed an asymmetric sensorineural hearing loss (worse on the right).
Computed tomography (CT) of the temporal bones demonstrated a 4 × 3.5 × 4-cm destructive mass centered in the right mastoid bone. The lesion had caused erosion of the mastoid bone down to the dura, the surrounding sigmoid sinus, and the posterior wall of the external auditory canal. The middle ear and jugular foramen did not appear to be involved.
MRI of the skull base demonstrated an intermediate T1 and T2 signal mass centered in the right mastoid bone, with numerous flow voids within the homogeneously enhancing mass (figure 2). The mass had invaded the external auditory canal, encroached on the lateral wall of the jugular bulb and sigmoid sinus, and abutted the posterior margin of the deep lobe of the parotid gland. These radiologic findings suggested a hypervascular lesion that did originate in the jugular foramen or middle ear.
The patient underwent cerebral angiography with embolization of the right occipital, posterior auricular, and middle meningeal arteries. He subsequently underwent surgery via a right postauricular infratemporal fossa approach with complete resection of the temporal bone lesion. Intraoperative findings included a 4-cm tumor that appeared to have originated in the vertical segment of the facial nerve. The tumor had caused erosion of the bone overlying the sigmoid sinus, and it extended into the petrous apex. An extradural tumor removal was performed after subtotal petrosectomy exposure with facial nerve preservation. The tumor, which had filled the mastoid cavity, was removed in a piecemeal fashion. It was dissected from the posterior portion of the vertical segment of the facial nerve, through the stylomastoid foramen, and along the extratemporal portion of the nerve. Although the facial nerve was surrounded by tumor, it was left anatomically intact after complete tumor removal.
A portion of the tumor was sent for pathologic evaluation, and findings on frozen-section analysis were compatible with a paraganglioma. Histopathologic evaluation revealed epithelioid cells with fibrovascular septae that divided the cells into a Zellballen pattern. The cells were either polygonal or spindle-shaped, and they exhibited abundant granular eosinophilic cytoplasm.
At the patient's clinic visit 1 year later, his wound was well healed and his facial nerve function was normal.
Subjectively, he reported good hearing, and his surveillance MRI of the skull base was negative for tumor. Patient 3. A 56-year-old woman reported experiencing decreased hearing and right-sided pulsatile tinnitus for the previous 5 months. Her medical history was unremarkable.
Microscopic otoscopy of the right ear revealed the presence of a pulsatile, reddish mass behind an intact tympanic membrane. Her facial nerve function was normal, and no abnormalities were observed on the remainder of the head and neck examination. Audiometry revealed a right-sided conductive hearing loss.
CT of the temporal bone showed a soft-tissue mass within the right hypotympanum that extended into the sinus tympani and facial recess. The initial differential diagnosis included glomus tympanicum and glomus jugulare, but because the bone between the tumor and the jugular bulb was intact on imaging and filled with what appeared to be the usual bone marrow, the preoperative diagnosis was a large glomus tympanicum.
Cerebral angiography with embolization of the right occipital artery was performed 1 day before surgery. The angiogram demonstrated a 2-cm hypervascular mass centered in the right mastoid bone.
The patient underwent excision of the tumor via a right transmastoid transcanal approach. Findings at the time of surgery included a tumor in the posterior hypotympanum that extended superiorly to the level of the posterior semicircular canal and inferiorly to the level of the jugular bulb. The tumor was encountered in the retrofacial air cell tract, and it was noted to have originated in the medial surface of the vertical segment of the facial nerve. The tumor was completely removed by a combination of drilling, curettage, and bipolar coagulation. At the completion of the procedure, the tympanic segment of the facial nerve was stimulated, and the response was normal.
Findings on histopathologic evaluation of the excised specimen were consistent with a glomus tumor. Follow-up at 1 month postoperatively revealed normal hearing and normal facial nerve function.
Discussion
Paraganglioma of the facial nerve is exceedingly rareas mentioned, only 12 cases have been previously reported in the literature (table) 2,4-12 -but it should still be included in the differential diagnosis of gradual-onset facial paralysis.
It is interesting that none of our 3 patients presented with facial weakness. Patient 1 presented with a left parotid mass and pulsatile tinnitus; patient 2 with a right external auditory mass, hearing loss, aural fullness, and pulsatile tinnitus; and patient 3 with a mass behind an intact tympanic membrane, a right conductive hearing loss, and pulsatile tinnitus. In addition to these signs and symptoms and facial paralysis, other clinical findings described in the literature have included otalgia, positional vertigo, disequilibrium, and dysgeusia.
MRI of the skull base was obtained for further diagnosis in our patient 1, and it demonstrated an enhancing left parotid gland mass with extension toward the left mastoid bone. Paragangliomas classically exhibit a hyperintense signal on T2 weighting, enhancement on T1 weighting, and scattered intratumor flow voids. 2 In patient 2, CT revealed the presence of a large, destructive mass that involved the mastoid cortex and ear canal and caused erosion down to the dura and the surrounding sigmoid sinus. In patient 3, CT demonstrated a mass in the right hypotympanum with involvement of the right mastoid bone.
Because paragangliomas enhance with contrast administration, they can be distinguished from nonenhancing disease processes such as cholesteatoma. Depending on preoperative imaging, the differential diagnosis of glomus faciale may be a primary parotid tumor, a vestibular schwannoma, a facial neuroma, or a minor salivary gland neoplasm. 3 Histologic evaluation of glomus faciale tumors, like all paragangliomas, shows cells arranged in the Zellballen pattern of cell clusters within a richly vascularized meshwork of capillaries. This cellular pattern, as well as the gross appearance of a bright red mass, is classic for paraganglioma.
Management options for glomus faciale include surgical resection, radiologic surveillance, and radiotherapy. Timely recognition of the disease is critical before the development of facial paralysis. Once facial nerve function has been compromised, complete tumor resection followed by nerve grafting is recommended. 12 In 10 of the 12 previously reported cases, the glomus faciale tumors were treated with complete tumor resection, including the involved facial nerve segment. Facial reanimation was performed with a greater auricular or sural nerve interposition graft, a hypoglossal-facial nerve graft, or cross-facial nerve grafting. 4, 5, [7] [8] [9] [10] [11] [12] In 3 of these cases, postoperative facial nerve function recovered to a House-Brackmann grade III within 2 to 4 years. 2, 5, 7 Preoperative angiography and embolization is helpful in cases of glomus faciale, as it is with all glomus tumors. 5, 12 While most of the reported cases of glomus faciale were managed with radical tumor and facial nerve resections, a nerve-sparing approach can be used in selected patients who present with normal facial nerve function.
Our patient 1 presented with full facial nerve function despite intraoperative findings of tumor intimately associated with the facial nerve. Because radical resection would have left her with complete facial paralysis, a tumor biopsy with transmastoid facial nerve decompression was performed. Surveillance MRI 8 years later revealed 4 mm of tumor growth, but the patient had complete facial nerve and auditory function. Paragangliomas are typically slowly growing tumors with a documented median growth rate of 1.0 mm per year. 13 Our patient 2 also presented with normal facial nerve function, and his tumor was amenable to complete resection without compromising the integrity of the facial nerve.
Finally, patient 3 underwent complete tumor removal via a transmastoid transcanal approach. Her facial nerve function was normal both pre-and postoperatively.
Treatment options in addition to surgery include external-beam radiotherapy (45 to 50 Gy) and stereotactic radiosurgery (12 to 18 Gy). 2 Petrus and Lo described 2 cases of glomus faciale treated with external-beam radiotherapy. 6 Unfortunately, they did not report any follow-up data regarding facial nerve function or tumor growth. External-beam irradiation has been used to treat glomus jugulare tumors in elderly patients, as well as for residual or recurrent lesions. Reported tumor control rates have ranged from 74 to 97% and complication rates from 4 to 20%. [14] [15] [16] [17] [18] Bianchi et al described the use of CyberKnife radiosurgery in the treatment of 9 patients with a paraganglioma of the skull base. 19 The use of this modality for glomus faciale has not been documented.
Patient factors such as age and comorbid conditions, as well as the risk of injury to adjacent neurovascular structures with surgery should be considered when deciding which treatment to undertake.
As described in our first case study, a conservative treatment approach consisting of transmastoid facial nerve decompression and periodic imaging surveillance may be ideal for patients with full facial nerve function and a smaller glomus faciale tumor. Complete tumor resection with preservation of facial nerve function is possible in selected cases, as occurred in our second and third cases.
In conclusion, our 3 cases illustrate the importance of considering facial paraganglioma, particularly in the context of pulsatile tinnitus. None of our patients exhibited facial weakness at presentation, and all were successfully managed with facial nerve preservation surgery and periodic imaging surveillance.
